Targeted Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis cultures using Illumina MiSeq and Nanopore MinION: Comparison of analytical and diagnostic performance, turnaround time and cost
Authors:
- Ketema TafessKTKetema Tafess
- Timothy Ting Leung NgTNTimothy Ting Leung Ng
- Hiu Yin LaoHLHiu Yin Lao
- Kenneth Siu Sing LeungKLKenneth Siu Sing Leung
- Kingsley King Gee TamKTKingsley King Gee Tam
- Rahim RajwaniRRRahim Rajwani
- Sarah Tsz Yan TamSTSarah Tsz Yan Tam
- Lily Pui Ki HoLHLily Pui Ki Ho
- Corey Mang Kiu ChuCCCorey Mang Kiu Chu
- Dimitri GonzalezDGDimitri Gonzalez
- Chalom SayadaCSChalom Sayada
- Oliver Chiu Kit MaOMOliver Chiu Kit Ma
Preprint
Abstract
The emergence of Mycobacterium tuberculosis strains with complex drug resistance profiles necessitates a rapid and extensive drug susceptibility test for comprehensive guidance of patient treatment. Here, we developed two targeted-sequencing workflows based on Illumina MiSeq and Nanopore MinION for the prediction of drug resistance in M. tuberculosis towards 12 anti-tuberculous agents. A total of 163 M. tuberculosis cultured isolates collected from Hong Kong and Ethiopia were subjected to a multiplex PCR for simultaneous amplification of 19 drug-resistance associated genetic regions. The amplicons were then barcoded and sequenced in parallel on MiSeq and MinION in respective batch sizes of 24 and 12 samples. Both platforms successfully sequenced all samples with average depths of coverage of 1,127× and 1,649× respectively. Utilizing a self-developed Web-based bioinformatics pipeline, Bacteriochek-TB, for variant analysis, we found that the MiSeq and MinION result could achieve 100% agreement if variants with an allele frequency of M. tuberculosis with complex drug resistance profiles. Molecular assays for rapid and comprehensive drug resistance profiling of M. tuberculosis are lacking. Here, we described targeted-sequencing workflows based on Illumina MiSeq and Nanopore MinION for the detection of drug resistance mutations scattered across 19 genetic regions in M. tuberculosis . A bioinformatics pipeline was also developed to translate raw datasets into clinician-friendly reports that provide comprehensive genetic information for the prediction of drug resistance towards 12 antibiotics. This is the first study to evaluate and compare the uses of Illumina and Nanopore platforms for diagnosis of drug-resistant tuberculosis. Remarkably, our diagnostic strategy is compatible with different sequencing platforms that can be applied in diagnostic centres with different levels of throughput and financial support for TB diagnosis.Keywords
All Related Versions
- Published version: Clinical Chemistry, 66 (6), 809.
This publication has 47 references indexed in Scilit:
- Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samplesBMC Infectious Diseases, 2017
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisThe Lancet Respiratory Medicine, 2017
- Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic ValueAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 SystemJournal of Clinical Microbiology, 2016
- Clinical use of whole genome sequencing for Mycobacterium tuberculosisBMC Medicine, 2016
- The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolatesScientific Reports, 2016
- Clinical Application of Whole-Genome Sequencing To Inform Treatment for Multidrug-Resistant Tuberculosis CasesJournal of Clinical Microbiology, 2015
- Comparison of Xpert MTB/RIF with Line Probe Assay for Detection of Rifampin-Monoresistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2014
- Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genesNature Genetics, 2013
- Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistanceNature Genetics, 2013